Biotech company moves forward with phase 2 trial for precision cancer surgery
Category: News
Scottish Medicines Consortium recommends pembrolizumab
Phase 1 trial of IRL757 demonstrates good absorption and safety profile
Largest real-world study demonstrates significant survival advantage
ISM001-055 shows promise in improving lung function among patients
Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid
Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe
New government scheme to offer routine opt-out blood tests
£3m programme to accelerate new antimicrobial treatment
International think tanks to shape future of cancer research funding